Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Surg Oncol. 2021 Dec 31;40:101696. doi: 10.1016/j.suronc.2021.101696

Fig. 2.

Fig. 2.

Inclusion criteria for patients with mass-forming intrahepatic cholangiocarcinoma in the (A) surgical and (B) medical cohorts. Abbreviations: CT, computed tomography; GEMCIS, gemcitabine + cisplatin.